A test developed by BG Medicine (Waltham, Massachusetts) could give physicians far greater insight on how to assess patients diagnosed with chronic heart failure. The company's test, Galectin-3 has approval in the U.S. and is said by the firm to be the first cardiac test cleared by the FDA in five years. (Medical Device Daily) Read More
